RED LIGHT HOLLAND CORP. - Asset Resilience Ratio
RED LIGHT HOLLAND CORP. (4YX) has an Asset Resilience Ratio of 3.54% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2024)
This chart shows how RED LIGHT HOLLAND CORP.'s Asset Resilience Ratio has changed over time. Check RED LIGHT HOLLAND CORP. strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down RED LIGHT HOLLAND CORP.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 4YX market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €644.32K | 3.54% |
| Total Liquid Assets | €644.32K | 3.54% |
Asset Resilience Insights
- Limited Liquidity: RED LIGHT HOLLAND CORP. maintains only 3.54% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
RED LIGHT HOLLAND CORP. Industry Peers by Asset Resilience Ratio
Compare RED LIGHT HOLLAND CORP.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
Drug Manufacturers - Specialty & Generic | 3.47% |
|
Tonghua Dongbao Pharmaceutical Co Ltd
SHG:600867 |
Drug Manufacturers - Specialty & Generic | 0.76% |
|
Beijing Winsunny Pharmaceutical CO.LTD
SHG:601089 |
Drug Manufacturers - Specialty & Generic | 10.89% |
|
Akums Drugs and Pharmaceutical
NSE:AKUMS |
Drug Manufacturers - Specialty & Generic | 28.08% |
|
Cronos Group Inc
TO:CRON |
Drug Manufacturers - Specialty & Generic | 69.94% |
|
Tibet Weixinkang Medicine Co Ltd
SHG:603676 |
Drug Manufacturers - Specialty & Generic | 40.81% |
|
Kamada
TA:KMDA |
Drug Manufacturers - Specialty & Generic | 0.00% |
Annual Asset Resilience Ratio for RED LIGHT HOLLAND CORP. (2022–2024)
The table below shows the annual Asset Resilience Ratio data for RED LIGHT HOLLAND CORP..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-03-31 | 0.00% | €0.00 ≈ $0.00 |
€24.08 Million ≈ $28.16 Million |
-- |
| 2023-03-31 | 0.15% | €45.50K ≈ $53.19K |
€30.14 Million ≈ $35.24 Million |
-1.45pp |
| 2022-03-31 | 1.60% | €527.81K ≈ $617.07K |
€32.94 Million ≈ $38.51 Million |
-- |
About RED LIGHT HOLLAND CORP.
Red Light Holland Corp. engages in the production, growth, and sale of functional mushrooms and mushroom home grow kits to the recreational market in North America and Europe. The company is also involved in the selection, distribution, and export of truffles, cannabidiol products, cannabis seeds, headshop products, growshop goods, cannabis bake house muffins, cookies, and cakes. It sells its pro… Read more